Chris Riley

Chris Riley is the co-founder and editor-in-chief of Peptide Injections AI. He previously founded and operated USARx.com for over a decade — one of the earliest digital health platforms in the prescription savings space — giving him deep, firsthand expertise in pharmacy economics, patient access, and healthcare technology at scale. Beyond the business side, Chris brings years of personal experience with peptide therapy and injectable protocols as an avid health enthusiast and competitive athlete, informing the platform's evaluations with real-world patient perspective.

He holds the Chartered Financial Analyst (CFA) designation and applies rigorous analytical frameworks to provider comparison and pricing transparency. He is also the co-founder of Experts.Ink, a medical writing agency staffed by licensed clinicians, where he oversees content operations and quality standards. His career has spanned health policy, clinical content strategy, pharmacy benefit design, and healthcare go-to-market across multiple verticals.